YCBD YCBD
Company Profile ↓Company Overview
YCBD (YCBD) is a publicly traded company listed on with a market capitalization of $4.55M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 32.4% per year over the last five years.
Carries low leverage with a debt-to-equity ratio of 0.11.
Recent Developments
- Sep 2025 Revenue of $19.19M (-1.5% YoY); net profit $-2.04M.
- Trailing 12 Months Year-on-year growth — revenue -1.5%.
- 5-Year Trend Long-term compounding — revenue CAGR -18.5%, profit CAGR 32.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -18.46% |
| 1 Year: | -1.50% |
Compounded Profit Growth
| 5 Years: | 32.36% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -41.05% |
| 6 Months: | -34.24% |
| 3 Months: | -41.66% |
| 1 Month: | -25.44% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)32.65 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Profit CAGR of 32.4% over 5 years.
CONS
- Revenue declined at -18.5% CAGR over 5 years.
- Trading 77.7% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 4.75M | 4.61M | 4.72M | 5.02M | 5.64M |
| Cost of Revenue | - | 1.79M | 1.78M | 1.94M | 2.02M | 2.38M |
| Gross Profit | - | 2.96M | 2.83M | 2.78M | 3.00M | 3.26M |
| Operating Expenses | - | 3.45M | 3.74M | 3.46M | 3.29M | 4.06M |
| Operating Income | - | -485.82K | -904.69K | -685.82K | -286.29K | -800.78K |
| EBITDA | - | 89.92K | -456.17K | -253.28K | 130.34K | -378.05K |
| Interest Expense | - | - | - | - | - | - |
| Pretax Income | - | -480.76K | -895.27K | -679.97K | -283.13K | -797.98K |
| Tax Provision | - | - | - | - | - | - |
| Net Income | - | -480.76K | -895.27K | -679.97K | -283.13K | -797.98K |
| Diluted EPS | -1.73 | -1.90 | -0.21 | - | -0.04 | -0.08 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Revenue | - | 35.40M | 24.16M | 19.48M | 19.19M |
| Cost of Revenue | - | 13.07M | 9.18M | 7.49M | 7.22M |
| Gross Profit | - | 22.34M | 14.98M | 12.00M | 11.97M |
| Operating Expenses | - | 39.65M | 24.25M | 15.31M | 14.13M |
| Operating Income | - | -17.31M | -9.27M | -3.32M | -2.16M |
| EBITDA | - | -14.34M | -6.34M | -1.49M | -366.67K |
| Interest Expense | 28.93K | - | - | - | - |
| Pretax Income | - | -70.08M | -22.94M | -3.70M | -2.04M |
| Tax Provision | - | 0 | 0 | 0 | 0 |
| Net Income | - | -70.08M | -22.94M | -3.70M | -2.04M |
| Diluted EPS | - | -446.40 | -106.56 | -14.29 | -1.09 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 40.79M | 16.20M | 10.58M | 10.42M |
| Current Assets | - | 16.01M | 8.07M | 6.39M | 6.55M |
| Cash & Equivalents | - | 6.72M | 1.80M | 2.45M | 2.26M |
| Inventory | - | 4.26M | 4.05M | 2.37M | 2.73M |
| Receivables | - | 1.45M | 1.22M | 983.91K | 1.04M |
| Total Liabilities | - | 9.37M | 7.16M | 8.62M | 3.19M |
| Current Liabilities | - | 5.29M | 4.67M | 8.62M | 3.19M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 4.87M | 3.68M | 1.27M | 778.24K |
| Total Equity | - | 31.42M | 9.03M | 1.96M | 7.23M |
| Shares Outstanding | - | 168.51K | 370.07K | 492.38K | 8.92M |
Cash Flows (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -14.97M | -4.30M | -352.79K | -1.45M |
| Investing Cash Flow | - | -688.68K | 702.45K | -290.01K | -184.17K |
| Financing Cash Flow | - | -4.04M | -1.32M | 1.30M | 1.45M |
| Capital Expenditure | - | -688.68K | -297.55K | -290.01K | -184.17K |
| Free Cash Flow | - | -15.66M | -4.60M | -642.81K | -1.64M |
| Net Change in Cash | - | -19.69M | -4.92M | 654.69K | -191.31K |
Ratios (Annual)
Figures in %.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 63.1% | 62.0% | 61.6% | 62.4% |
| Operating Margin % | - | -48.9% | -38.4% | -17.0% | -11.3% |
| Net Margin % | - | -198.0% | -95.0% | -19.0% | -10.6% |
| ROE % | - | -223.0% | -254.0% | -188.5% | -28.2% |
| ROCE % | - | -48.8% | -80.4% | -168.9% | -29.9% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Worth Venture Partners, Llc | 1.76% | 184.80K | $93.67K |
| 2 | UBS Group AG | 1.57% | 164.64K | $83.46K |
| 3 | CSS LLC | 1.31% | 137.62K | $69.76K |
| 4 | Xtx Topco Ltd | 0.88% | 92.05K | $46.66K |
| 5 | Chapin Davis, Inc. | 0.77% | 81.25K | $41.19K |
| 6 | Chicago Partners Investment Group LLC | 0.74% | 78.10K | $39.59K |
| 7 | Jane Street Group, LLC | 0.73% | 76.34K | $38.70K |
| 8 | Alesco Advisors, LLC | 0.65% | 68.51K | $34.73K |
| 9 | Vanguard Capital Management LLC | 0.49% | 51.05K | $25.88K |
| 10 | Vanguard Fiduciary Trust Co | 0.45% | 47.16K | $23.90K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for YCBD
YCBD — Frequently Asked Questions
What is the current share price of YCBD?
As of 2026-08-02 19:16 PDT, YCBD trades at $0.51 on NASDAQ/NYSE. Its 52-week range is $0.47 to $2.27.
What is the market capitalisation of YCBD?
YCBD has a market capitalisation of $4.55M on NASDAQ/NYSE.
What is the P/E ratio of YCBD?
YCBD trades at a trailing price-to-earnings (P/E) ratio of -0.47. Its price-to-book (P/B) ratio is 0.63.
What is the return on equity (ROE) of YCBD?
YCBD has a return on equity (ROE) of -28.24%. Its return on capital employed (ROCE) is -29.93%.
Is YCBD a good stock to buy?
This page provides a data-driven analysis of YCBD, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.